Small G-protein Rho is involved in the maintenance of cardiac myocyte morphology

Journal of Cellular Biochemistry

Volumn 95, Issue 3, 2005, Pages 529-542

  Grounds, Haslett R ^a   Ng, Dominic C H ^a   Bogoyevitch, Marie A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atrial natriuretic factor; Cultured cardiac myocytes; Myocyte morphology; Myocyte size; Protein delivery; Rho; Small g proteins

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; PENETRATIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSACTIVATOR PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SIZE; CELL TYPE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; METABOLISM;

ANIMALS; CELLS, CULTURED; MYOCYTES, CARDIAC; RATS; RHOA GTP-BINDING PROTEIN;

EID: 23944451684     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20441     Document Type: Article

References (43)

1. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W, Kadowaki T, Yazaki Y. 1999. Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 84:458-466.
2. Aikawa R, Komuro I, Nagai R, Yazaki Y. 2000. Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes. Mol Cell Biochem 212: 177-182.
3. Aktories K, Hall A. 1989. Botulinum ADP-ribosyltransferase C3: A new tool to study low molecular weight GTP-binding proteins. Trends Pharmacol Sci 10:415-418.
4. Allen WE, Jones GE, Pollard JW, Ridley AJ. 1997. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 110:707-720.
5. Allen WE, Zicha D, Ridley AJ, Jones GE. 1998. A role for Cdc42 in macrophage chemotaxis. J Cell Biol 141:1147-1157.
6. Aoki H, Izumo S, Sadoshima J. 1998. Angiotensin II activates RhoA in cardiac myocytes. A critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 82:666-676.
7. Arai A, Spencer JA, Olson EN. 2002. Stars, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277:24453-24459.
8. Boettner B, van Aelst L. 2002. The role of Rho GTPases in disease development. Gene 286:155-174.
9. Bogoyevitch MA, Kendrick TS, Ng DCH, Barr RK. 2002. Taking the cell by stealth or storm? Protein transduction domains (PTDs) as versatile vectors for delivery. DNA Cell Biol 21:879-894.
10. Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM. 1989. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J 8: 1087-1092.
11. Chen L, Wright LR, Chen CH, Oliver SF, Wender PA, Mochly-Rosen D. 2001. Molecular transporters for peptides: Delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol 8:1123-1129.
12. Chen M, Won DJ, Krajewski S, Gottlieb RA. 2002. Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem 277:29181-29186.
13. Clerk A, Sugden PH. 2000. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 86:1019-1023.
14. Clerk A, Pham FH, Fuller SJ, Sahai E, Aktories K, Marais R, Marshall C, Sugden PH. 2001. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol Cell Biol 21:1173-1184.
15. Demali KA, Burridge K. 2003. Coupling membrane protrusion and cell adhesion. J Cell Sci 116:2389-2397.
16. Gottshall KR, Hunter JJ, Tanaka N, Dalton N, Decker KD, Ross J, Chien KR. 1997. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc Natl Acad Sci USA 94:4710-4715.
17. Gustafsson AB, Sayen MR, Williams SD, Crow MT, Gottlieb RA. 2002. TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective. Circulation 106: 735-739.
18. Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA. 2004. Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279:21233-21238.
19. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
20. Hilal-Dandan R, Means CK, Gustafsson AB, Morissette MR, Adams JW, Brunton LL, Heller Brown J. 2004. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J Mol Cell Cardiol 36:481-493.
21. Hines WA, Thorburn A. 1998. Ras and Rho are required for Gα-induced hypertrophic gene expression in neonatal rat cardiac myocytes. J Mol Cell Cardiol 30:485-494.
22. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. 1998. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 273:7725-7730.
23. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR. 1995. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270:23173-23178.
24. Inagaki K, Hahn HS, Dorn GW, Mochly-Rosen D. 2003. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108:869-875.
25. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420.
26. Marinissen MJ, Chiariello M, Gutkind JS. 2001. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 γ) MAP kinase pathway. Genes Dev 15: 535-553.
27. Nagai T, Tanaka-Ishikawa M, Aikawa R, Ishihara H, Zhu W, Yazaki Y, Nagai R, Komuro I. 2003. Cdc42 plays a critical role in assembly of sarcomere units in series of cardiac myocytes. Biochem Biophys Res Commun 305: 806-810.
28. Ng DCH, Long CS, Bogoyevitch MA. 2001. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein Kinases in Interleukin-1-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem 276:29490-29498.
29. Ridley AJ. 2001. Rho family proteins: Coordinating cell responses. Trends Cell Biol 11:471-477.
30. Rubin EJ, Gill DM, Boquet P, Popoff MR. 1988. Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol 8:418-426.
31. Sah VP, Hoshijima M, Chien KR, Heller Brown J. 1996. Rho is required for Gaq and a1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 271:31185-31190.
32. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW, Ross J, Chien KR, Brown JH. 1999. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 103: 1627-1634.
33. Sahai E, Marshall CJ. 2002. Rock and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol 4:408-415.
34. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G. 2001. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104.
35. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. 1999. In vivo protein transduction delivery of a biologically important protein into the mouse. Science 285:1569-1572.
36. Souchet M, Portales-Casamar E, Mazurais D, Schmidt S, Leger I, Javre JL, Robert P, Berrebi-Bertrand I, Bril A, Gout B, Debant A, Calmels TP. 2002. Human p63Rho-GEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere. J Cell Sci 115: 629-640.
37. Sugden PH, Clerk A. 2000. Activation of the small GTP-binding protein Ras in the heart by hypertrophic agonists. Trends Cardiovasc Med 10:1-8.
38. Sugioka R, Shimizu S, Funatsu T, Tamagawa H, Sawa Y, Kawakami T, Tsujimoto Y. 2003. BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo. Oncogene 22:8432-8440.
39. Thorburn J, Xu S, Thorburn A. 1997. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J 16:1899-1900.
40. Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL. 2003. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302:1775-1779.
41. Winton MJ, Dubreuil CI, Lasko D, Leclerc N, Mckerracher L. 2002. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J Biol Chem 277: 32820-32829.
42. Worthylake RA, Burridge K. 2003. RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem 278:13578-13584.
43. Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T, Sasayama S. 2002. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J Biol Chem 277:8618-8625.